RxDoctor Payments DataLook up a doctor →

Martin Zaiac, MD

MOHS-Micrographic Surgery · Miami Beach, FLNPI 1215979398

Payments from drug & device makers

$592,905in general payments, 2019–2025

Across 994 payments — averaging $596.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$323K
  • VYNE Pharmaceuticals Inc.$136K
  • Dermavant Sciences, Inc.$54K
  • AbbVie$25K
  • Galderma Laboratories, L.p.$19K
  • Sun Pharmaceutical Industries Inc.$9K
  • plus $27K from 34 others
$10,365in research payments, 2019–2025

Across 3 payments — averaging $3454.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$10K
  • Acera Surgical, Inc.$506

What the payments were for

  • Consulting fees$8,79514%
  • Speaking & faculty fees$27,43845%
  • Travel & lodging$1,0192%
  • Food & beverage$23,50538%
  • Education$3821%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$592,905 in reported general payments places this provider in the 95th percentile of 141 mohs-micrographic surgery providers in Florida.

See all mohs-micrographic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$589,159
Medicare patients
818
Services billed
6,943

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinolone AcetonideFluocinolone/Shower Cap40$1,813
Triamcinolone Acetonide182$1,758
Doxycycline Hyclate152$1,694
ValacyclovirValacyclovir Hcl44$1,690
Fluorouracil26$1,671
Cephalexin214$1,476
Clobetasol Propionate44$1,360
Minoxidil76$1,011
Doxepin Hcl18$511
Ketoconazole22$388
Mupirocin44$369
Terbinafine Hcl38$338
Fluconazole26$328
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$127
Finasteride15$103

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Miami Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →